-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NmG7p5QNVDnnzXnk1r6Zj5BFRZenO8dgCw2C57sdCIG8QMePFZ+Kbbwe+jBV9ptY bg6P7Hv/vXJGLnieeL88ag== 0000950137-06-006970.txt : 20060619 0000950137-06-006970.hdr.sgml : 20060619 20060619172654 ACCESSION NUMBER: 0000950137-06-006970 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20060619 DATE AS OF CHANGE: 20060619 GROUP MEMBERS: CLESTON LORD GROUP MEMBERS: DANNIEL E. STEVENS GROUP MEMBERS: JACQUELYN MARIE LEE-STEVENS GROUP MEMBERS: ROBERT CLOUSE GROUP MEMBERS: ROBERT MOTON GROUP MEMBERS: SONDRA BELL GROUP MEMBERS: STEVENS FINANCIAL GROUP, INC. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UNITED MEDICORP INC CENTRAL INDEX KEY: 0000831460 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] IRS NUMBER: 752217002 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-40750 FILM NUMBER: 06913640 BUSINESS ADDRESS: STREET 1: 10210 N CENTRAL EXPRWY SUITE 400 CITY: DALLAS STATE: TX ZIP: 75231-3499 BUSINESS PHONE: 2146912140 MAIL ADDRESS: STREET 2: 10210 N CENTRAL EXPWAY SUITE 400 CITY: DALLAS STATE: TX ZIP: 752313499 FORMER COMPANY: FORMER CONFORMED NAME: GAMMA RESOURCES INC DATE OF NAME CHANGE: 19890724 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: STEVENS FINANCIAL GROUP LLC CENTRAL INDEX KEY: 0001216026 IRS NUMBER: 330899100 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 3333 WARRENVILLE ROAD STREET 2: SUITE 200 CITY: LISLE STATE: IL ZIP: 60532 BUSINESS PHONE: 6302458666 MAIL ADDRESS: STREET 1: 3333 WARRENVILLE ROAD STREET 2: SUITE 200 CITY: LISLE STATE: IL ZIP: 60532 SC 13D 1 c06144sc13d.txt SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 United Medicorp, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 910852201 (CUSIP Number) Danniel E. Stevens Stevens Financial Group, L.L.C. 3333 Warrenville Road, Suite 200 Lisle, Illinois 60532 with a copy to: Jeffrey M. Weiner DLA Piper Rudnick Gray Cary LLP* 1999 Avenue of the Stars, Fourth Floor Los Angeles, California 90067-6022 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) June 7, 2006 (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ] * As counsel solely to Danniel E. Stevens and Stevens Financial Group, L.L.C. CUSIP No. 910852201 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NUMBERS Stevens Financial Group, L.L.C. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS WC - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Illinois - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 1,299,000 ---------------------------------------------------------------- NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY 470,000 OWNED BY EACH ---------------------------------------------------------------- REPORTING 9 SOLE DISPOSITIVE POWER PERSON WITH 1,299,000 ---------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 470,000 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON For the reporting person named on this cover page: 1,769,000 shares For the group filing on this Schedule 13D: 2,180,250 shares - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [X] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) For the reporting person named on this cover page: 5.7%* For the group filing on this Schedule 13D: 7.1%* - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON OO (limited liability company) - -------------------------------------------------------------------------------- * Based upon 30,768,550 Shares stated to be outstanding as of May 4, 2006 by the Issuer in its Form 10-Q filing, filed with the Securities and Exchange Commission on May 15, 2006. CUSIP No. 910852201 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NUMBERS Danniel E. Stevens - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS PF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 5,000 ---------------------------------------------------------------- 8 SHARED VOTING POWER NUMBER OF SHARES 1,764,000 BENEFICIALLY ---------------------------------------------------------------- OWNED BY EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH 5,000 ---------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 1,764,000 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON For the reporting person named on this cover page: 1,769,000 shares For the group filing on this Schedule 13D: 2,180,250 shares - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [X] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) For the reporting person named on this cover page: 5.7%* For the group filing on this Schedule 13D: 7.1%* - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN (individual) - -------------------------------------------------------------------------------- * Based upon 30,768,550 Shares stated to be outstanding as of May 4, 2006 by the Issuer in its Form 10-Q filing, filed with the Securities and Exchange Commission on May 15, 2006. CUSIP No. 910852201 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NUMBERS Robert Moton - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS PF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 ---------------------------------------------------------------- 8 SHARED VOTING POWER NUMBER OF SHARES 450,000 BENEFICIALLY ---------------------------------------------------------------- OWNED BY EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH 0 ---------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 450,000 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON For the reporting person named on this cover page: 450,000 shares For the group filing on this Schedule 13D: 2,180,250 shares - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [X] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) For the reporting person named on this cover page: 1.5%* For the group filing on this Schedule 13D: 7.1%* - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN (individual) - -------------------------------------------------------------------------------- * Based upon 30,768,550 Shares stated to be outstanding as of May 4, 2006 by the Issuer in its Form 10-Q filing, filed with the Securities and Exchange Commission on May 15, 2006. CUSIP No. 910852201 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NUMBERS Jacquelyn Marie Lee-Stevens - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS PF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 ---------------------------------------------------------------- 8 SHARED VOTING POWER NUMBER OF SHARES 15,000 BENEFICIALLY ---------------------------------------------------------------- OWNED BY EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH 0 ---------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 15,000 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON For the reporting person named on this cover page: 15,000 shares For the group filing on this Schedule 13D: 2,180,250 shares - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [X] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) For the reporting person named on this cover page: Less than 0.1%* For the group filing on this Schedule 13D: 7.1%* - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN (individual) - --------------- ---------------------------------------------------------------- * Based upon 30,768,550 Shares stated to be outstanding as of May 4, 2006 by the Issuer in its Form 10-Q filing, filed with the Securities and Exchange Commission on May 15, 2006. CUSIP No. 910852201 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NUMBERS Sondra Bell - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS PF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 ---------------------------------------------------------------- 8 SHARED VOTING POWER NUMBER OF SHARES 40,000 BENEFICIALLY ---------------------------------------------------------------- OWNED BY EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH 0 ---------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 40,000 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON For the reporting person named on this cover page: 40,000 shares For the group filing on this Schedule 13D: 2,180,250 shares - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [X] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) For the reporting person named on this cover page: 0.1%* For the group filing on this Schedule 13D: 7.1%* - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN (individual) - -------------------------------------------------------------------------------- * Based upon 30,768,550 Shares stated to be outstanding as of May 4, 2006 by the Issuer in its Form 10-Q filing, filed with the Securities and Exchange Commission on May 15, 2006. CUSIP No. 910852201 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NUMBERS Cleston Lord - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS PF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 185,000 ---------------------------------------------------------------- 8 SHARED VOTING POWER NUMBER OF SHARES 40,000 BENEFICIALLY ---------------------------------------------------------------- OWNED BY EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH 185,000 ---------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 40,000 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON For the reporting person named on this cover page: 225,000 shares For the group filing on this Schedule 13D: 2,180,250 shares - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [X] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) For the reporting person named on this cover page: 0.7%* For the group filing on this Schedule 13D: 7.1%* - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN (individual) - -------------------------------------------------------------------------------- * Based upon 30,768,550 Shares stated to be outstanding as of May 4, 2006 by the Issuer in its Form 10-Q filing, filed with the Securities and Exchange Commission on May 15, 2006. CUSIP No. 910852201 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NUMBERS Robert Clouse - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS PF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 186,250 ---------------------------------------------------------------- 8 SHARED VOTING POWER NUMBER OF SHARES 0 BENEFICIALLY ---------------------------------------------------------------- OWNED BY EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH 186,250 ---------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 0 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON For the reporting person named on this cover page: 186,250 shares For the group filing on this Schedule 13D: 2,180,250 shares - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [X] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) For the reporting person named on this cover page: 0.6%* For the group filing on this Schedule 13D: 7.1%* - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN (individual) - -------------------------------------------------------------------------------- * Based upon 30,768,550 Shares stated to be outstanding as of May 4, 2006 by the Issuer in its Form 10-Q filing, filed with the Securities and Exchange Commission on May 15, 2006. ITEM 1. SECURITY AND ISSUER. This statement on Schedule 13D relates to the common stock, par value $.01 per share (the "Shares"), of United Medicorp, Inc., a Delaware corporation (the "Issuer"). The principal executive offices of the Issuer are located at 200 N. Cuyler Street, Pampa, Texas 79065. ITEM 2. IDENTITY AND BACKGROUND. This Schedule 13D is filed by (i) Stevens Financial Group, L.L.C., an Illinois limited liability company ("SFG"), (ii) Danniel E. Stevens, a citizen of the United States, (iii) Robert Moton, a citizen of the United States, (iv) Jacquelyn Marie Lee-Stevens, a citizen of the United States, (v) Sondra Bell, a citizen of the United States, (vi) Cleston Lord, a citizen of the United States and (vii) Robert Clouse, a citizen of the United States (collectively the "Reporting Parties"). The principal business address of each of the Reporting Parties is c/o Stevens Financial Group, L.L.C., 3333 Warrenville Road, Suite 200, Lisle, Illinois 60532. Mr. Stevens is the managing member and sole manager of SFG and Chief Executive Officer of Stevens Equity Holdings, a unit of SFG. SFG is engaged in financial consulting, evaluating, investing in and acquiring businesses. In the normal course of its business, SFG may identify investment opportunities which the Reporting Parties may pursue in their discretion. Mr. Lord is Vice President of SFG. Mr. Moton is presently retired and is Mr. Stevens' father. Ms. Lee-Stevens is a human resource services manager and is Mr. Stevens' wife. Ms. Bell is a borough administrator and is Mr. Lord's mother. Mr. Clouse is a vice president of a financial services company and a friend of Mr. Stevens. During the last five (5) years, none of the Reporting Parties has been convicted of any criminal proceeding (excluding traffic violations and similar misdemeanors). During the last five (5) years none of the Reporting Parties has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. Beneficial ownership of the Shares of the Issuer to which this statement relates was acquired with working capital of SFG and personal funds of each of the Reporting Parties. ITEM 4. PURPOSE OF TRANSACTION. The Reporting Parties are filing this schedule together because they may be deemed to be a "group" (as defined in the rules and regulations promulgated by the Securities and Exchange Commission under section 13(d) of the Securities Exchange Act of 1934, as amended) by reason of: (a) personal, familial and business relations between and among them, specifically the fact that (i) Mr. Lord is the Vice President of SFG, (ii) Ms. Bell is Mr. Lord's mother and has given Mr. Lord the authority to acquire, dispose and vote securities held in her name, (iii) Mr. Moton is Mr. Stevens' father and has granted Mr. Stevens the power to acquire, dispose and vote securities held in his name, (iv) Ms. Lee-Stevens is Mr. Stevens' wife and has granted Mr. Stevens the power to acquire, dispose and vote securities held in her name and (v) Mr. Clouse is a friend of Mr. Stevens; and (b) the fact that they have, on occasion in the past, discussed their common view that the Shares represent an attractive investment opportunity for each of them and they may have similar discussions in the future. The Reporting Parties acquired and hold their shares for investment purposes. One or more of them may in the future acquire additional Shares, subject to market conditions and other considerations they deem relevant. Also based on the same considerations, the Reporting Parties may dispose of Shares. They may also seek, individually or collectively, to communicate with the Company regarding its business and financial condition. However, they have no present intention to engage in any of the activities listed in Items (a) through (j) of Schedule 13D with respect to the Company. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a) As of the close of business on June 16, 2006, SFG and Mr. Stevens may each be deemed to beneficially own 1,769,000 Shares representing approximately 5.7% of the Issuer's outstanding Shares (based upon the 30,768,550 Shares stated to be outstanding as of May 4, 2006 by the Issuer in its Form 10-Q filing, filed with the Securities and Exchange Commission on May 15, 2006). Of these Shares, SFG and Mr. Stevens directly own 1,299,000 and 5,000 Shares, respectively, which represent approximately 4.2% and 0.02% of the Issuer's outstanding Shares, respectively (based on 30,768,550 Shares outstanding). Mr. Stevens may be deemed for certain purposes to share beneficial ownership of 465,000 Shares owned by Ms. Lee-Stevens and Mr. Moton by reason of the understandings and relationships described in Item 6. By virtue of Mr. Stevens' relationship with SFG (as disclosed in Item 2), SFG may be deemed to share beneficial ownership of the 465,000 Shares owned by Ms. Lee-Stevens and Mr. Moton. Each of the Reporting Persons disclaims beneficial ownership of the Shares owned by any of the other Reporting Persons for any purpose except to the extent specifically set forth above. (b) SFG and Mr. Stevens may be deemed to have the sole power to vote or direct the vote and to dispose or to direct the disposition of 1,299,000 and 5,000 Shares, respectively. Mr. Stevens and SFG each may be deemed to have shared power to vote or direct the vote and to dispose or to direct the disposition of (i) 450,000 Shares owned by Robert H. Moton and (ii) 5,000 Shares owned by Jacquelyn Marie Lee-Stevens. Mr. Lord may be deemed to have shared power to vote or direct the vote and to dispose or to direct the disposition of 40,000 Shares owned by Sondra Bell in addition to 185,000 Shares owned directly by Mr. Lord. Mr. Clouse has sole dispositive and voting power of 186,250 Shares. (c) The following table sets forth all transactions with respect to Shares effected during the past sixty (60) days by any of the Reporting Parties. All such transactions were effected in the open market and the table includes commissions paid.
REPORTING PARTY/OWNER DATE NO. OF SHARES PURCHASED PRICE PER SHARE - ----------------------- -------- ----------------------- --------------- Stevens Financial Group 05/23/06 1,000 0.0200 Stevens Financial Group 06/06/06 425,434 0.0200 Stevens Financial Group 06/07/06 475,000 0.0200 Stevens Financial Group 06/08/06 45,000 0.0200 Stevens Financial Group 06/09/06 53,566 0.0200 Robert Clouse 06/09/06 5,000 0.0200 Robert Clouse 06/09/06 5,000 0.0200 Robert Clouse 06/09/06 5,000 0.0200 Robert Clouse 06/09/06 5,000 0.0225 Robert Clouse 06/09/06 5,000 0.0225 Cleston Lord 06/13/06 5,000 0.0200 Cleston Lord 06/13/06 5,000 0.0200 Cleston Lord 06/13/06 5,000 0.0200 Stevens Financial Group 06/14/06 75,000 0.0195 Stevens Financial Group 06/15/06 20,000 0.0195 Stevens Financial Group 06/16/06 49,000 0.0195
(d) None. (e) Not applicable. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER. Mr. Stevens has an understanding with Mr. Moton pursuant to which Mr. Stevens has voting and dispositive power over the Shares owned by Mr. Moton. This voting and dispositive power can be revoked at any time by Mr. Moton. Mr. Stevens is married to Ms. Lee-Stevens and has an understanding with Ms. Lee-Stevens pursuant to which Mr. Stevens has voting and dispositive power over the Shares owned by Ms. Lee-Stevens. By virtue of Mr. Stevens' relationship with SFG (as disclosed in Item 2), Mr. Stevens may be deemed to have voting and dispositive power over Shares held by SFG, and SFG may be deemed to have voting and dispositive power over the Shares held by Mr. Stevens, Mr. Moton and Ms. Lee-Stevens. Mr. Lord is Vice President of SFG and Ms. Bell is Mr. Lord's mother. Mr. Lord has an understanding with Ms. Bell pursuant to which Mr. Lord has voting and dispositive power over the Shares owned by Ms. Bell. This voting and dispositive power can be revoked at any time by Ms. Bell. Mr. Clouse is a friend of Mr. Stevens. SFG and Mr. Stevens initially identified the Shares as a potential investment opportunity. Except as described herein, none of the Reporting Parties has any contracts, arrangements, understandings or relationships (legal or otherwise) with any person with respect to any securities of the Issuer, including but not limited to the transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. 1. Joint Filing Agreement 2. Powers of Attorney SIGNATURES After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: June 19, 2006 By: /s/ Danniel E. Stevens ------------------------------------ Name: Danniel E. Stevens STEVENS FINANCIAL GROUP, L.L.C. By: /s/ Danniel E. Stevens ------------------------------------ Name: Danniel E. Stevens Its: Managing Member By: /s/ Danniel E. Stevens ------------------------------------ Danniel E. Stevens As Attorney-in-Fact for Robert Moton, Jacquelyn Marie Lee-Stevens, Sondra Bell, Cleston Lord and Robert Clouse EX-99.1 2 c06144exv99w1.txt JOINT FILING AGREEMENT EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common stock, $.01 par value per share, of United Medicorp, Inc., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 19th day of June, 2006. STEVENS FINANCIAL GROUP, L.L.C /s/ Robert H. Moton By: /s/ Danniel E. Stevens - ------------------------------------- ------------------------------------ Robert H. Moton Name: Danniel E. Stevens Its: Managing Member /s/ Danniel E. Stevens /s/ Jacquelyn Marie Lee-Stevens - ------------------------------------- ---------------------------------------- Danniel E. Stevens Jacquelyn Marie Lee-Stevens /s/ Sondra Bell /s/ Cleston Lord - ------------------------------------- ---------------------------------------- Sondra Bell Cleston Lord /s/ Robert Clouse - ------------------------------------- Robert Clouse EX-99.2 3 c06144exv99w2.txt POWER OF ATTORNEY EXHIBIT 99.2 POWER OF ATTORNEY The undersigned does hereby constitute and appoint DANNIEL E. STEVENS as the true and lawful attorney and agent of the undersigned to execute on behalf of the undersigned (i) a statement on Schedule 13D (including any amendments thereto) with respect to the common stock, $.01 par value per share, of United Medicorp, Inc. (together with any amendments thereto, the "Schedule 13D"), and (ii) a Joint Filing Agreement by and among the undersigned, Danniel E. Stevens, Stevens Financial Group, L.L.C. and certain other individuals relating to the Schedule 13D. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 19th day of June, 2006. /s/ Robert H. Moton ---------------------------------------- Robert H. Moton EX-99.3 4 c06144exv99w3.txt POWER OF ATTORNEY EXHIBIT 99.3 POWER OF ATTORNEY The undersigned does hereby constitute and appoint DANNIEL E. STEVENS as the true and lawful attorney and agent of the undersigned to execute on behalf of the undersigned (i) a statement on Schedule 13D (including any amendments thereto) with respect to the common stock, $.01 par value per share, of United Medicorp, Inc. (together with any amendments thereto, the "Schedule 13D"), and (ii) a Joint Filing Agreement by and among the undersigned, Danniel E. Stevens, Stevens Financial Group, L.L.C. and certain other individuals relating to the Schedule 13D. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 19th day of June, 2006. /s/ Jacquelyn Marie Lee-Stevens ---------------------------------------- Jacquelyn Marie Lee-Stevens EX-99.4 5 c06144exv99w4.txt POWER OF ATTORNEY EXHIBIT 99.4 POWER OF ATTORNEY The undersigned does hereby constitute and appoint DANNIEL E. STEVENS as the true and lawful attorney and agent of the undersigned to execute on behalf of the undersigned (i) a statement on Schedule 13D (including any amendments thereto) with respect to the common stock, $.01 par value per share, of United Medicorp, Inc. (together with any amendments thereto, the "Schedule 13D"), and (ii) a Joint Filing Agreement by and among the undersigned, Danniel E. Stevens, Stevens Financial Group, L.L.C. and certain other individuals relating to the Schedule 13D. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 19th day of June, 2006. /s/ Sondra Bell ---------------------------------------- Sondra Bell EX-99.5 6 c06144exv99w5.txt POWER OF ATTORNEY EXHIBIT 99.5 POWER OF ATTORNEY The undersigned does hereby constitute and appoint DANNIEL E. STEVENS as the true and lawful attorney and agent of the undersigned to execute on behalf of the undersigned (i) a statement on Schedule 13D (including any amendments thereto) with respect to the common stock, $.01 par value per share, of United Medicorp, Inc. (together with any amendments thereto, the "Schedule 13D"), and (ii) a Joint Filing Agreement by and among the undersigned, Danniel E. Stevens, Stevens Financial Group, L.L.C. and certain other individuals relating to the Schedule 13D. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 19th day of June, 2006. /s/ Cleston Lord ---------------------------------------- Cleston Lord EX-99.6 7 c06144exv99w6.txt POWER OF ATTORNEY EXHIBIT 99.6 POWER OF ATTORNEY The undersigned does hereby constitute and appoint DANNIEL E. STEVENS as the true and lawful attorney and agent of the undersigned to execute on behalf of the undersigned (i) a statement on Schedule 13D (including any amendments thereto) with respect to the common stock, $.01 par value per share, of United Medicorp, Inc. (together with any amendments thereto, the "Schedule 13D"), and (ii) a Joint Filing Agreement by and among the undersigned, Danniel E. Stevens, Stevens Financial Group, L.L.C. and certain other individuals relating to the Schedule 13D. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 19th day of June, 2006. /s/ Robert Clouse ---------------------------------------- Robert Clouse -----END PRIVACY-ENHANCED MESSAGE-----